Post hoc integrated data analysis showed significant but smaller EET improvements for both UMEC/VI doses versus placebo at Week 12 ( UMEC/VI 125/25mcg : 47.5 s ; p = 0.002 ; UMEC/VI 62.5 / 25 mcg : 43.7 s ; p = 0.001 ) .